摘要
目的:探讨半肝及肝三叶切除术在临床应用的安全性和可行性。方法:2005年6月至2008年6月,我们实施半肝切除19例,肝三叶切除6例。其中左半肝切除8例,右半肝切除11例,巨大肝癌20例,巨大肝血管瘤4例,肝包虫病1例。结果:全组术中无死亡,术后发生明显并发症6例,其中腹水3例,胸腔积液2例,胆瘘1例。肝癌患者中术后生存超过12个月19例(95%),24个月13例(65%),36个月7例(35%)。结论:掌握手术指征和手术技巧,并作好围手术期处理,半肝及肝三叶切除术是安全、有效的。
Objective： To explore the safety and feasibility of trisegmentectomy and hemihepatectomy in clinic.Methods： June 2005-June 2008 we implemented trisegmentectomy in 19 cases and hemihepatectomy 6 cases of liver disease,which including 8 cases of left-hemihepatectomy,8 cases of right-hemihepatectomy,20 cases of giant liver cancer,4 giant hepatic haemangioma,1 hepatic echinococcosis.Results： The whole group were no deaths in operation,6 cases of significant complications occurred after operation,in-cluding 3 cases of ascites,2 cases of pleural effusion,1case of biliary fistula.Of patients with liver cancer,19 cases have survived over 12 months,13 cases over 24 monthes and 7 cases over 30 months.Conclusion： With strict indication,operative skill and proper preoperative treatment,trisegmentectomy and hemihepatectomy is still safe and feasible.
出处
《现代生物医学进展》
CAS
2012年第11期2117-2119,共3页
Progress in Modern Biomedicine
关键词
半肝切除
肝三叶切除
肝癌
Hemihepatectomy
Thymopetidum
Liver cancer
